Exploring Drug Delivery to the Peritoneum (eBook, PDF)

Redaktion: Shegokar, Ranjita

• Format: PDF

Produktbeschreibung

The¿Peritoneal cavity (PC) is the key metastatic site for¿intra-abdominal malignancies (e.g., GI tract and rectal cancer). PC sites can be used tötarget several other diseases where lymphatic drug delivery is desired without dumping large amounts of the drug. Until recently, it was thought that treatment with¿curative intent was impossible but¿that was challenged by¿the¿introduction of¿cytoreductive surgery (CRS), heated intraperitoneal chemotherapy (HIPEC), and PIPAC (pressurized intraperitoneal aerosol chemotherapy). Recently, a growing number of¿preclinical and clinical studies advocate intraperitoneal (IP) chemotherapy as an alternative post-operative therapy for cancer. Although their effectiveness has been proven both experimentally and clinically, there is still little understanding of the role of¿drug delivery systems in targeting drugs in the¿intraperitoneal (IP) cavity. There are two main challenges posed to such therapies 1) the complexity of IP cavity and 2) the drug transport dynamics e.g., the residence time of¿small molecular weight drugs, the fate of delivery systems (both nano and micro), etc. The¿present book is a link between pharmaceutical scientists (drug formulators), clinicians, and toxicologists. This book also provides a new perspective töresearchers tödivert or guide their research in an optimal way. Exploring Drug Delivery töthe¿Peritoneum serves as a platform for¿upcoming technologies especially in the medical devices sector töface up and show potential in delivering drugs to IP cavity. It is a chance for¿commercial partners like¿insurance companies and the pharma industry töexplore the old administration route in a new way.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer International Publishing
• Seitenzahl: 242
• Erscheinungstermin: 30. November 2023
• Englisch
• ISBN-13: 9783031316944
• Artikelnr.: 69569470

Autorenporträt

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. For the last many years, she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles. Currently, she serves as a Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research at numerous national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited several trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received numerous prestigious national and international awards among them include recently received the prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting, and the role of excipients in delivery systems (www.ranjitas.com).

Inhaltsangabe

Chapter 1: Peritoneal Organ-Anatomical and Physiological Considerations.- Chapter 2: drug delivery platforms for intra-peritoneal delivery focusing primarily on need, delivery systems, clinical progress, market and regulatory aspects.- Chapter 3: Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems.- Chapter 4: Nano and micro/medicines for intraperitoneal therapy in ovarian cancer: critical overview and focus on pharmaceutical manufacturing under cGMP.- Chapter 5: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India.- Chapter 6: HIPEC: Concept and Fundamentals in Colorectal Cáncer Peritoneal Mestatasis Treatment.- Chapter 7: Peritoneal Implants and Drug Delivery.- Chapter 8: Importance of Computational Models in Development of Intrapertitoneal Administration based Drug Delivery Systems for Solid Tumors.- Chapter 9: Drug Delivery Systems for peritonium : current status and Future perspectives.- Chapter 10: Exploring the Intraperitoneal Route in a New Way for Preclinical Testing.